中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共2条，第1-2条 帮助

已选(0)清除 条数/页：   排序方式：
Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study 期刊论文
BMC CANCER, 2023, 卷号: 23
作者:  Cao, Fei;  Shi, Changsheng;  Zhang, Guofu;  Luo, Jun;  Zheng, Jiaping;  Hao, Weiyuan
收藏  |  浏览/下载：10/0  |  提交时间：2023/11/10
Hepatocellular carcinoma  Atezolizumab  Bevacizumab  Overall survival  Progression-free survival  
Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard treatment regimens 期刊论文
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021
作者:  Cao, Fei;  Zheng, Jiaping;  Luo, Jun;  Zhang, Zhewei;  Shao, Guoliang
收藏  |  浏览/下载：59/0  |  提交时间：2021/08/30
Regorafenib plus DEB-TACE  CRLM  Treatment response  Prognosis  Adverse events